新生儿黄疸不会影响儿童的远期发育

 
 
根据一项最新研究发现，与其他婴儿相比，新生儿黄疸的诊断与治疗不会影响婴儿的远期发育。

美国San Francisco的California大学(UCSF, USA)与Kaiser Permanente的研究分部(Oakland, CA, USA)的研究人员，比较了140胆红素水平在25 mg/dl和30 mg/dl之间的婴儿（该水平在700例新生儿中只有1例能够达到）和400多例的对照婴儿。研究人员对这些儿童进行了随访直到5岁，检测他们的智商(IQ)、神经系统，并对其父母进行访问。他们结果发现在IQ或者行为方面、或者发生异常神经系统检查结果或者疾病诊断的儿童比例等方面，黄疸儿童与对照儿童之间没有显著性差异。这些研究结果发表在2006年5月《新英格兰医学期刊之上》。
 
Newborns With Jaundice Develop Normally
 
Newborn babies who are diagnosed with and treated for jaundice are no more likely than other babies to suffer long-term developmental problems, according to a new study.

Researchers from the University of California, San Francisco (UCSF, USA) and Kaiser Permanente's Division of Research (Oakland, CA, USA) compared 140 infants with bilirubin levels of between 25 mg/dl and 30 mg/dl--a level reached by only about 1 in 700 newborns---to more than 400 control infants. The researchers followed the children up to five years of age, measuring intelligence quotient (IQ), performing neurologic exams, and interviewing parents. They found no significant difference between jaundiced and control newborns in IQ or behavior, or in the proportion of children with abnormal neurologic examinations or with neurologic diagnoses. The study was published in the May 4, 2006, issue of the New England Journal of Medicine.